CCR7 Antikörper (AA 25-59)
-
- Target Alle CCR7 Antikörper anzeigen
- CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))
-
Bindungsspezifität
- AA 25-59
-
Reaktivität
- Human, Maus, Ratte, Schaf
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CCR7 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Ratte, Schaf
- Homologie
- Dog
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from mouse CCR7
- Isotyp
- IgG
-
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 43, Issue 2, pp. 531-539, (2017) (PubMed).
: "A possible link between loading, inflammation and healing: Immune cell populations during tendon healing in the rat." in: Scientific reports, Vol. 6, pp. 29824, (2016) (PubMed).
: "Integration of nondegradable polystyrene and degradable gelatin in a core-sheath nanofibrous patch for pelvic reconstruction." in: International journal of nanomedicine, Vol. 10, pp. 3193-201, (2015) (PubMed).
: "
-
High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 43, Issue 2, pp. 531-539, (2017) (PubMed).
-
- Target
- CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))
- Andere Bezeichnung
- CCR7/CD197 (CCR7 Produkte)
- Synonyme
- zgc:165629 antikoerper, ccr7-a antikoerper, CD197 antikoerper, Cdw197 antikoerper, Cmkbr7 antikoerper, EBI1 antikoerper, Ebi1h antikoerper, BLR2 antikoerper, CDw197 antikoerper, CMKBR7 antikoerper, chemokine (C-C motif) receptor 7 antikoerper, C-C motif chemokine receptor 7 antikoerper, C-C motif chemokine receptor 7 L homeolog antikoerper, ccr7 antikoerper, CCR7 antikoerper, ccr7.L antikoerper, Ccr7 antikoerper
- Hintergrund
-
Synonyms: EBI1, CCR-7, CD197, Ebi1h, Cdw197, Cmkbr7, CC-CKR-7, C-C chemokine receptor type 7, C-C CKR-7, Epstein-Barr virus-induced G-protein coupled receptor 1, EBV-induced G-protein coupled receptor 1, MIP-3 beta receptor, Ccr7
Background: CCR7 is a member of the G protein coupled receptor family (subfamily : chemokine). This receptor was identified as a gene induced by the Epstein Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. CCR7 has been reported to be expressed in blood, bone marrow, lymph node, and intestine. It is particularly expressed in lymphoid tissues and in activated B and T lymphocytes and has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor. ESTs have been isolated from blood, embryo, lymph node, and thymus libraries.
- Gen-ID
- 12775
- UniProt
- P47774
- Pathways
- Regulation of Actin Filament Polymerization, Positive Regulation of Immune Effector Process
-